Related CAS: | 223673-34-5 (free base) |
IUPAC Name: | (1R)-2-[2-(4-nitrophenyl)ethylamino]-1-phenylethanol;hydrochloride |
Description: | An impurity of Mirabegron. Mirabegron (formerly YM-178, trade name Myrbetriq) is a drug for the treatment of overactive bladder. It was developed by Astellas Pharma and was approved in the United States in July 2012. Mirabegron activates the β3 adrenergic receptor in the detrusor muscle in the bladder, which leads to muscle relaxation and an increase in bladder capacity. |
Molecular Weight: | 322.78 |
Molecular Formula: | C16H19ClN2O3 |
Canonical SMILES: | C1=CC=C(C=C1)[C@H](CNCCC2=CC=C(C=C2)[N+](=O)[O-])O.Cl |
InChI: | InChI=1S/C16H18N2O3.ClH/c19-16(14-4-2-1-3-5-14)12-17-11-10-13-6-8-15(9-7-13)18(20)21;/h1-9,16-17,19H,10-12H2;1H/t16-;/m0./s1 |
InChI Key: | LUAUJCGKCGBAKA-NTISSMGPSA-N |
Melting Point: | 202-205 °C |
Solubility: | Soluble in DMSO (Slightly), Water (Slightly) |
Appearance: | Pale Yellow Solid |
LogP: | 4.17660 |
Customer Support
If the product you need is not in our catalog, please contact us in time to submit your needs. You can help our website get better and better. Why not submit the request today?
Customer Centered
Related Functional Groups
Alcohols and Derivatives
Customers Also Viewed
Copyright © 2024 BOC Sciences. All rights reserved.
Our Products